CASTLE BIOSCIENCES, INC. Selling, General and Administrative Expense
CASTLE BIOSCIENCES, INC. (CSTL) reported Selling, General and Administrative Expense of $66.12 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $66.12M, a 13.88% increase year-over-year.
- CASTLE BIOSCIENCES, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $64.90M, a 10.71% increase year-over-year.
- CASTLE BIOSCIENCES, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $56.73M, a 13.54% increase year-over-year.
- CASTLE BIOSCIENCES, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $55.91M, a 10.71% increase year-over-year.
- CASTLE BIOSCIENCES, INC. selling, general and administrative expense for fiscal 2025 was $229.32M, a 14.63% increase from fiscal 2024.
- CASTLE BIOSCIENCES, INC. selling, general and administrative expense for fiscal 2024 was $200.05M, a 11.04% increase from fiscal 2023.
- CASTLE BIOSCIENCES, INC. selling, general and administrative expense for fiscal 2023 was $180.15M, a 25.98% increase from fiscal 2022.
- CASTLE BIOSCIENCES, INC. selling, general and administrative expense for fiscal 2022 was $143.00M, a 64.87% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $66.12M 10-Q · filed 2026-07-30 | $131.02M 10-Q · filed 2026-07-30 | $187.75M derived: sum of 3 quarters · filed 2026-07-30 | $243.66M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2026-03-31 | $64.90M 10-Q · filed 2026-05-06 | $121.63M derived: sum of 2 quarters · filed 2026-05-06 | $177.54M derived: sum of 3 quarters · filed 2026-05-06 | $235.60M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-12-31 | $56.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $112.64M derived: sum of 2 quarters · filed 2026-02-26 | $170.70M derived: sum of 3 quarters · filed 2026-07-30 | $229.32M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $55.91M 10-Q · filed 2025-11-03 | $113.97M derived: sum of 2 quarters · filed 2026-07-30 | $172.59M 10-Q · filed 2025-11-03 | $222.56M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-06-30 | $58.06M 10-Q · filed 2026-07-30 | $116.69M 10-Q · filed 2026-07-30 | $166.65M derived: sum of 3 quarters · filed 2026-07-30 | $217.15M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-03-31 | $58.62M 10-Q · filed 2026-05-06 | $108.58M derived: sum of 2 quarters · filed 2026-05-06 | $159.08M derived: sum of 3 quarters · filed 2026-05-06 | $210.17M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $49.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $100.46M derived: sum of 2 quarters · filed 2026-02-26 | $151.55M derived: sum of 3 quarters · filed 2026-02-26 | $200.05M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $50.50M 10-Q · filed 2025-11-03 | $101.59M derived: sum of 2 quarters · filed 2025-11-03 | $150.08M 10-Q · filed 2025-11-03 | $194.17M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | $51.09M 10-Q · filed 2025-08-04 | $99.58M 10-Q · filed 2025-08-04 | $143.67M derived: sum of 3 quarters · filed 2026-02-26 | $188.29M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | $48.49M 10-Q · filed 2025-05-05 | $92.58M derived: sum of 2 quarters · filed 2026-02-26 | $137.20M derived: sum of 3 quarters · filed 2026-02-26 | $181.88M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $44.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $88.71M derived: sum of 2 quarters · filed 2026-02-26 | $133.39M derived: sum of 3 quarters · filed 2026-02-26 | $180.15M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $44.62M 10-Q · filed 2024-11-04 | $89.30M derived: sum of 2 quarters · filed 2024-11-04 | $136.06M 10-Q · filed 2024-11-04 | $174.49M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-06-30 | $44.68M 10-Q · filed 2024-08-05 | $91.44M 10-Q · filed 2024-08-05 | $129.87M derived: sum of 3 quarters · filed 2025-02-27 | $166.50M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-03-31 | $46.76M 10-Q · filed 2024-05-02 | $85.19M derived: sum of 2 quarters · filed 2025-02-27 | $121.81M derived: sum of 3 quarters · filed 2025-02-27 | $159.31M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | $38.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $75.05M derived: sum of 2 quarters · filed 2025-02-27 | $112.55M derived: sum of 3 quarters · filed 2025-02-27 | $143.00M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $36.63M 10-Q · filed 2023-11-02 | $74.12M derived: sum of 2 quarters · filed 2023-11-02 | $104.58M 10-Q · filed 2023-11-02 | $129.74M derived: sum of 4 quarters · filed 2023-11-02 | |||
| 2022-06-30 | $37.50M 10-Q · filed 2023-08-02 | $67.95M 10-Q · filed 2023-08-02 | $93.11M derived: sum of 3 quarters · filed 2023-08-02 | $115.71M derived: sum of 4 quarters · filed 2023-08-02 | |||
| 2022-03-31 | $30.45M 10-Q · filed 2023-05-03 | $55.61M derived: sum of 2 quarters · filed 2023-05-03 | $78.21M derived: sum of 3 quarters · filed 2023-05-03 | $99.03M derived: sum of 4 quarters · filed 2023-05-03 | |||
| 2021-12-31 | $25.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $47.76M derived: sum of 2 quarters · filed 2023-02-28 | $68.58M derived: sum of 3 quarters · filed 2023-02-28 | $86.74M 10-K · filed 2023-02-28 | |||
| 2021-09-30 | $22.59M 10-Q · filed 2022-11-02 | $43.42M derived: sum of 2 quarters · filed 2022-11-02 | $61.58M 10-Q · filed 2022-11-02 | $76.54M derived: sum of 4 quarters · filed 2022-11-02 | |||
| 2021-06-30 | $20.82M 10-Q · filed 2022-08-08 | $38.98M 10-Q · filed 2022-08-08 | $53.94M derived: sum of 3 quarters · filed 2022-08-08 | $65.64M derived: sum of 4 quarters · filed 2022-08-08 | |||
| 2021-03-31 | $18.16M 10-Q · filed 2022-05-09 | $33.12M derived: sum of 2 quarters · filed 2022-05-09 | $44.82M derived: sum of 3 quarters · filed 2022-05-09 | $55.22M derived: sum of 4 quarters · filed 2022-05-09 | |||
| 2020-12-31 | $14.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $26.66M derived: sum of 2 quarters · filed 2022-02-28 | $37.05M derived: sum of 3 quarters · filed 2022-02-28 | $48.13M 10-K · filed 2022-02-28 | |||
| 2020-09-30 | $11.70M 10-Q · filed 2021-11-08 | $22.09M derived: sum of 2 quarters · filed 2021-11-08 | $33.17M 10-Q · filed 2021-11-08 | $43.02M derived: sum of 4 quarters · filed 2021-11-08 | |||
| 2020-06-30 | $10.39M 10-Q · filed 2021-08-09 | $21.47M 10-Q · filed 2021-08-09 | $31.32M derived: sum of 3 quarters · filed 2021-08-09 | $38.44M derived: sum of 4 quarters · filed 2021-08-09 | |||
| 2020-03-31 | $11.08M 10-Q · filed 2021-05-10 | $20.93M derived: sum of 2 quarters · filed 2021-05-10 | $28.05M derived: sum of 3 quarters · filed 2021-05-10 | $34.87M derived: sum of 4 quarters · filed 2021-05-10 | |||
| 2019-12-31 | $9.85M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $16.97M derived: sum of 2 quarters · filed 2021-03-11 | $23.80M derived: sum of 3 quarters · filed 2021-03-11 | $29.84M 10-K · filed 2021-03-11 | |||
| 2019-09-30 | $7.12M 10-Q · filed 2020-11-09 | $7.12M 10-Q · filed 2019-11-12 | $13.94M derived: sum of 2 quarters · filed 2020-11-09 | $19.99M 10-Q · filed 2020-11-09 | $19.99M 10-Q · filed 2019-11-12 | $24.16M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $6.82M 10-Q · filed 2020-08-10 | $6.82M 10-Q · filed 2019-09-03 | $12.87M 10-Q · filed 2020-08-10 | $12.87M 10-Q · filed 2019-09-03 | $17.03M derived: sum of 3 quarters · filed 2020-08-10 | $20.95M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | $6.05M 10-Q · filed 2020-05-11 | $10.21M derived: sum of 2 quarters · filed 2020-05-11 | $14.13M derived: sum of 3 quarters · filed 2020-05-11 | $18.29M derived: sum of 4 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $4.17M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $8.08M derived: sum of 2 quarters · filed 2020-03-10 | $12.24M derived: sum of 3 quarters · filed 2020-03-10 | $16.47M 10-K · filed 2020-03-10 | |||
| 2018-09-30 | $3.92M 10-Q · filed 2019-11-12 | $8.08M derived: sum of 2 quarters · filed 2019-11-12 | $12.31M 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | $4.16M 10-Q · filed 2019-09-03 | $8.39M 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |